TheraRadar
Data updated: May 26, 2026

MECAMYLAMINE HYDROCHLORIDE

Cardiovascular Approved 2013-03-19

MECAMYLAMINE HYDROCHLORIDE is indicated for the treatment of Hypertension; Malignant Hypertension.

Source: FDA Label • LGM PHARMA
1
Indication
--
Phase 3 Trials
13
Years on Market

Details

Status
Prescription
First Approved
2013-03-19
Routes
ORAL
Dosage Forms
TABLET

Companies

Active Ingredient: MECAMYLAMINE HYDROCHLORIDE

MECAMYLAMINE HYDROCHLORIDE Approval History

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
1 FDA actions from 2013 to 2013
Mar 2013 ORIGINAL
Update

What MECAMYLAMINE HYDROCHLORIDE Treats

2 indications

MECAMYLAMINE HYDROCHLORIDE is approved for 2 conditions since its original approval in 2013. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Hypertension
  • Malignant Hypertension
Source: FDA Label

MECAMYLAMINE HYDROCHLORIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to MECAMYLAMINE HYDROCHLORIDE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ACEBUTOLOL HYDROCHLORIDE
ACEBUTOLOL HYDROCHLORIDE
1 shared
PHARMOBEDIENT
Shared indications:
ALDACTONE
SPIRONOLACTONE
1 shared
Pfizer
Shared indications:
ALISKIREN HEMIFUMARATE
ALISKIREN HEMIFUMARATE
1 shared
PH HEALTH
Shared indications:
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

MECAMYLAMINE HYDROCHLORIDE FDA Label Details

Indications & Usage

MECAMYLAMINE HYDROCHLORIDE is indicated for the treatment of Hypertension; Malignant Hypertension.

Looking for the branded version?

INVERSINE

Full clinical data, patents, trials, and competitive landscape for mecamylamine hydrochloride.

See INVERSINE

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.